Abstract
Fibromyalgia is a prevalent syndrome characterized by widespread pain in the absence of evident tissue injury or pathology, making it one of the most mysterious chronic pain conditions. The composition of the gut microbiota in individuals with fibromyalgia differs from that of healthy controls, but its functional role in the syndrome is unknown. Here, we show that fecal microbiota transplantation from fibromyalgia patients, but not from healthy controls, into germ-free mice induces pain and numerous molecular phenotypes that parallel known changes in fibromyalgia patients, including immune activation and metabolomic profile alterations. Replacing the fibromyalgia microbiota with a healthy microbiota substantially alleviated pain in mice. An open-label trial in women with fibromyalgia (Registry MOH_2021-11-04_010374) showed that transplantation of a healthy microbiota is associated with reduced pain and improved quality of life. We conclude that altered gut microbiota has a role in fibromyalgia pain, highlighting it as a promising target for therapeutic interventions.
Original language | English |
---|---|
Journal | Neuron |
Early online date | 18 Apr 2025 |
DOIs | |
State | E-pub ahead of print - 18 Apr 2025 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2025 The Author(s)
Keywords
- bile acid
- chronic pain
- fecal microbiota transplantation
- fibromyalgia
- germ-free
- immune system
- inflammation
- metabolism
- microbiome
- microglia
ASJC Scopus subject areas
- General Neuroscience